{'text': 'Why some new drugs are truly earning the ‘innovative’ label', 'publisher': {'href': 'https://www.biopharmadive.com', 'title': 'BioPharma Dive'}, 'created_at': 'Thu, 16 Jul 2015 07:00:00 GMT', 'description': 'Why some new drugs are truly earning the ‘innovative’ label  BioPharma Dive', 'url': 'https://news.google.com/rss/articles/CBMiogFBVV95cUxQU2xRcXV5UFNobXVvWmZKVDlxdFl4N3VLYXBpV1BzRVhaOFRIc2dPS0ZSTzBkRHlqa2lpREJsZ2NRdFJDOHZDdW5QN21KTHJEQkVBUzk4VTN0cXJfUWVDcklwTUVzdFZzZTBhT3Rnb1N4V3h0Y2hyYTJ5VS0tU0Z5UjdFWmVvei1CZktiTm1CaUJXRWtUZmZPS0NWaWJtSXlWUkE?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'For Clonz Biotech, biosimilars promise high rewards, high risks | Company Business News', 'publisher': {'href': 'https://www.livemint.com', 'title': 'Mint'}, 'created_at': 'Thu, 16 Jul 2015 07:00:00 GMT', 'description': 'For Clonz Biotech, biosimilars promise high rewards, high risks | Company Business News  Mint', 'url': 'https://news.google.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?oc=5&hl=en-US&gl=US&ceid=US:en'}
